HCA HCA Healthcare, Inc. Common Stock
Über HCA Healthcare, Inc. Common Stock Unternehmensübersicht von Wikipedia
Hospital Corporation of America (HCA) ist ein US-amerikanischer Betreiber von Gesundheitseinrichtungen an rund 2000 Standorten mit Sitz in Nashville, Tennessee. Dazu gehören etwa 185 Krankenhäuser, Chirurgiezentren, Notaufnahmen, Notfallzentren und Ärztekliniken in 21 Bundesstaaten und im Vereinigten Königreich.
Mehr lesen
Hospital Corporation of America (HCA) ist ein US-amerikanischer Betreiber von Gesundheitseinrichtungen an rund 2000 Standorten mit Sitz in Nashville, Tennessee. Dazu gehören etwa 185 Krankenhäuser, Chirurgiezentren, Notaufnahmen, Notfallzentren und Ärztekliniken in 21 Bundesstaaten und im Vereinigten Königreich.
Geschichte
Die Hospital Corporation of America wurde 1968 von Jack C. Massey, Thomas F. Frist Sr. und Thomas F. Frist Jr. gegründet. Bereits im Jahr 1956 hatte Thomas F. Frist Sr. begonnen das Park View Hospital in Nashville neu zu organisieren. Nachdem 1965 Medicaid und Medicare ins Leben gerufen wurden, nahm die Zahl der gemeinnützigen Krankenhäuser im ganzen Land rasch zu. Die Ärzte des Park View Hospital beschlossen, ihr Krankenhaus an eine Verwaltungsgesellschaft zu verkaufen. Sie baten den Geschäftsmann Jack Massey um Unterstützung und gründeten unter dem Namen Hospital Corporation of America eine eigene Verwaltungsgesellschaft. Das neue Unternehmen entwickelte sich zu einem der führenden privaten Gesundheitsdienstleister der Vereinigten Staaten. Bis 1979 standen 140 Krankenhäuser unter der Verwaltung der HCA. In der Mitte der 1980er Jahre gehörten über 200 Krankenhäuser zu der Krankenhauskette und weitere 200 hatten Verträge zur Verwaltung abgeschlossen.
Umstrukturierung und Expansion
In den Jahren von 1987 bis 1997 wurde das Unternehmen neu strukturiert, um so den Chancen und Herausforderungen der wettbewerbsorientierten Gesundheitsbranche gerecht zu werden. 104 Krankenhäuser der HCA wurden 1987 an die neu gegründete Healthtrust Corporation verkauft. Die verbliebenen 97 Krankenhäuser kamen im Februar 1994 im Zuge eines Zusammenschlusses mit der Columbia Hospital Corporation (CHC) zur Columbia/HCA. Richard Scott, der 1987 die Columbia Hospital Corporation in Texas gegründet hatte, wurde Chief Executive Officer (CEO) des neuen Unternehmens. 1991 bestand die CHC aus 12 Krankenhäusern, 1992 waren durch den Erwerb von Basic American Medical 8 Krankenhäuser, 1993 mit der Übernahme der Galen Health Care Corporation 71 Krankenhäuser und 1994 die 97 Krankenhäuser von HCA sowie die 96 ambulanten chirurgischen Zentren von Medical Care America hinzugekommen. Anschließend kamen 1995 noch einmal 117 Krankenhäuser durch den Erwerb von Healthtrust hinzu. 1997 besaß und betrieb Columbia/HCA über 340 Krankenhäuser mit Liegenschaften in 36 Bundesstaaten und zwei weiteren Ländern.
Betrugsverdacht und Neuorganisation
Zum 24. Juli 1997 trat Scott von seinem Posten als CEO zurück, da er im Verdacht stand, sich Gelder aus dem Medicare-Programm des Bundes erschlichen zu haben. Die Ermittler durchsuchten Krankenhäuser in sieben Bundesstaaten, um in den Abrechnungen Beweise für den Betrug zu finden. Thomas Frist Jr. wurde sein Nachfolger als CEO. Laut Recherchen der Associated Press wurden bis Ende August 1997 Einrichtungen der Columbia/HCA in zehn Bundesstaaten auf möglichen Medicaid-Betrug untersucht. Im Oktober 1997 wurde daraufhin von dem Unternehmen eine neue Abteilung für Ethik, Compliance und Unternehmensverantwortung eingerichtet. In der Folge reduzierte HCA innerhalb von drei Jahren die Zahl seiner Einrichtungen drastisch. Das obere Management wurde reorganisiert und das Unternehmen umbenannt.
Nach langwierigen Verhandlungen mit der Bundesregierung über die Columbia-Untersuchung mussten die Unternehmen im Jahr 2000 insgesamt 840 Millionen US-Dollar zahlen und eine Vereinbarung zur Unternehmensintegrität mit dem Generalinspektorat unterzeichnen. Gegen zwei nicht mehr existierende Tochterunternehmen, die Columbia Management Companies und die Columbia Homecare Group wurden weitere vierzehn Strafverfahren wegen des Vorwurfs unlauterer Absprachen, rechtswidriger Vergütung und falscher Angaben eingeleitet.
Trotz dieser Verfahren erwirtschaftete das Unternehmen im Jahr 2000 einen Umsatz von 16,7 Milliarden US-Dollar und einen Nettogewinn von 913 Millionen US-Dollar. Anfang 2001 gab das Unternehmen bekannt, dass der frühere Chief Operating Officer Jack O. Bovender Jr. der neue Chief Executive Officer des Unternehmens wird.
Der Fall wurde als größter Betrugsfall im Gesundheitswesen in der Geschichte der USA bezeichnet und endete 2003 mit einem Vergleich. Die festgesetzte Strafe betrug insgesamt 1,7 Milliarden US-Dollar. Zu den bereits am 14. Dezember 2000 gezahlten 840 Millionen US-Dollar kamen weitere Zivilstrafen und Schadensersatzansprüche in Höhe von 631 Millionen US-Dollar hinzu.
Jüngere Unternehmensgeschichte
Die HCA besitzt in den Vereinigten Staaten und seit 1995 auch im Vereinigten Königreich zahlreiche Immobilien von Krankenhäusern und beschäftigt als Krankenhausbetreiber rund 275.000 Mitarbeiter.
Seit November 2006 gehört HCA den US-amerikanischen Unternehmen Bain Capital und Kohlberg Kravis Roberts & Co., die das Unternehmen für insgesamt 21 Milliarden US-Dollar übernommen haben. Im November 2010 brachten die neuen Besitzer HCA unter dem Namen „HCA Holding, Inc.“ an die Börse.
Im März 2011 verkaufte HCA Holdings Inc. 126,2 Millionen Aktien für jeweils 30 US-Dollar. Trotz der hohen Verschuldung von HCA war die Nachfrage sehr groß und es kamen rund 3,79 Milliarden US-Dollar zusammen. Dies war der bis dahin größte durch Private Equity unterstützte Börsengang in der Geschichte der USA. Im Mai 2017 wurde das Unternehmen in „HCA Healthcare“ umbenannt.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
HCA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
HCA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 16. Juni 2026 | $0,7800 |
| 17. März 2026 | $0,7800 |
| 15. Dezember 2025 | $0,7200 |
| 16. September 2025 | $0,7200 |
| 16. Juni 2025 | $0,7200 |
| 17. März 2025 | $0,7200 |
| 13. Dezember 2024 | $0,6600 |
| 16. September 2024 | $0,6600 |
| 14. Juni 2024 | $0,6600 |
| 14. März 2024 | $0,6600 |
| 13. Dezember 2023 | $0,6000 |
| 14. September 2023 | $0,6000 |
| 15. Juni 2023 | $0,6000 |
| 16. März 2023 | $0,6000 |
| 13. Dezember 2022 | $0,5600 |
| 15. September 2022 | $0,5600 |
| 15. Juni 2022 | $0,5600 |
| 16. März 2022 | $0,5600 |
| 13. Dezember 2021 | $0,4800 |
| 15. September 2021 | $0,4800 |
HCA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 6 20,0%
- Kauf 11 36,7%
- Halten 12 40,0%
- Verkauf 1 3,3%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
21 Analysten · 2026-08-17Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $7.62 | $7.54 | 0.08% |
| 31. März 2026 | $7.15 | $7.21 | -0.06% |
| 31. Dezember 2025 | $8.14 | $7.53 | 0.61% |
| 30. September 2025 | $6.96 | $5.77 | 1.2% |
| 30. Juni 2025 | $6.83 | $6.31 | 0.52% |
| 31. März 2025 | $6.45 | $5.84 | 0.61% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | — |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | — |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | — |
| UHS | — | 9.4 | 9.7% | 8.6% | 21.4% | — |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | — |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | — |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | — |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | -482,587,000 | 232,891,000 | 239,173,000 | 246,936,000 | -523,751,000 | 256,763,000 | 261,156,000 | 264,435,000 | -550,173,000 | 271,173,000 | 274,494,000 | 276,910,000 | -590,583,000 | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | -488,037,000 | 236,181,000 | 241,911,000 | 249,440,000 | -530,198,000 | 259,917,000 | 264,071,000 | 268,016,000 | -558,171,000 | 275,424,000 | 278,198,000 | 280,961,000 | -598,621,000 | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Cashflow 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77.11B | $75.20B | · | $73.57B | $71.91B | $70.64B | · | $68.53B | $66.91B | $65.00B | · | $62.64B | $61.24B | $60.33B | · | $60.01B | |
| Net Income TTM | $6.62B | $6.53B | · | $6.18B | $5.99B | $5.93B | · | $5.40B | $5.32B | $5.23B | · | $4.77B | $4.84B | $4.92B | · | $5.83B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.7 | 17.3 | · | 17.0 | 16.2 | 15.2 | · | 20.1 | 16.3 | 17.6 | · | 14.5 | 17.9 | 15.7 | · | 9.7 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.5 | 1.2 | 1.4 | · | 1.1 | 1.4 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| P / FCF | · | 117.7 | · | · | · | 127.2 | · | · | · | 65.0 | · | · | · | 120.1 | · | · | |
| EV / EBITDA | 135.0 | 154.7 | · | 152.3 | 149.4 | 148.2 | · | 170.5 | 150.6 | 159.4 | · | 136.0 | 158.5 | 146.5 | · | 118.7 | |
| EV / FCF | · | 160.7 | · | · | · | 193.1 | · | · | · | 93.8 | · | · | · | 182.8 | · | · | |
| EV / Revenue | 1.7 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Earnings Yield | 7.3% | 5.8% | · | 5.9% | 6.2% | 6.6% | · | 5.0% | 6.1% | 5.7% | · | 6.9% | 5.6% | 6.4% | · | 10.3% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Nettoergebnis | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| Verwässerte EPS | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Liquiditätsgrad | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
- Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
- HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Bemerkenswerte Optionsaktivität am Donnerstag: HCA, HRTG, ZM
- HCA Healthcare (HCA) Finanzierungsstrategie erweitert – Hier erfahren Sie wie
- HCA Healthcare übertrifft Schätzungen für den vierteljährlichen Gewinn aufgrund der Nachfrage nach medizinischer Versorgung
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.486 Einreicher · $39.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 128 (-51 vs. Vorquartal) | 174 (+70 vs. Vorquartal) | 450 (-30 vs. Vorquartal) | 555 (-4 vs. Vorquartal) | +16.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.118.113.464 | 13.104.814 | 15,52% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.150.533 | 10.141.708 | 10,03% | Aktien |
| Sanders Capital, LLC | $3.442.060.818 | 8.828.287 | 8,73% | Aktien |
| STATE STREET CORP | $2.912.102.056 | 7.469.035 | 7,39% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.750.298.867 | 4.489.212 | 4,44% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.225.259.672 | 3.159.159 | 3,11% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.057.704.509 | 2.712.828 | 2,68% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861.456.107 | 2.209.485 | 2,19% | Aktien |
| NORGES BANK | $836.457.140 | 2.145.367 | 2,12% | Aktien |
| Capital World Investors | $770.864.224 | 1.977.121 | 1,96% | Aktien |
| Capital International Investors | $747.403.041 | 1.916.947 | 1,90% | Aktien |
| Crake Asset Management LLP | $449.072.183 | 1.151.792 | 1,14% | Aktien |
| Metropolis Capital Ltd | $430.915.307 | 910.564 | 1,09% | Aktien |
| Darsana Capital Partners LP | $428.879.000 | 1.100.000 | 1,09% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414.533.777 | 1.063.207 | 1,05% | Aktien |
| Life Cycle Investment Partners Ltd | $355.737.196 | 912.404 | 0,90% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $339.685.814 | 871.235 | 0,86% | Aktien |
| FMR LLC | $325.199.295 | 834.080 | 0,83% | Aktien |
| BARCLAYS PLC | $299.888.573 | 769.162 | 0,76% | Aktien |
| LYRICAL ASSET MANAGEMENT LP | $255.015.742 | 654.071 | 0,65% | Aktien |
| BlackRock, Inc. | $240.062.291 | 615.718 | 0,61% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235.649.908 | 604.401 | 0,60% | Aktien |
| National Pension Service | $230.650.346 | 591.578 | 0,59% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $230.189.125 | 594.466 | 0,58% | Aktien |
| GOLDMAN SACHS GROUP INC | $209.775.669 | 538.038 | 0,53% | Aktien |
| Gobi Capital LLC | $195.742.325 | 502.045 | 0,50% | Aktien |
| Cryder Capital Partners LLP | $194.561.738 | 499.017 | 0,49% | Aktien |
| Swiss National Bank | $172.097.446 | 441.400 | 0,44% | Aktien |
| AustralianSuper Pty Ltd | $159.635.782 | 409.438 | 0,41% | Aktien |
| Consulta Ltd | $155.956.000 | 400.000 | 0,40% | Aktien |
| LEE DANNER & BASS INC | $152.150.679 | 390.240 | 0,39% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151.472.265 | 388.500 | 0,38% | Kaufoption |
| Mitsubishi UFJ Asset Management Co., Ltd. | $147.943.761 | 379.450 | 0,38% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $139.697.405 | 358.300 | 0,35% | Aktien |
| Vanguard Global Advisers, LLC | $136.962.509 | 351.285 | 0,35% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $134.838.505 | 288.820 | 0,34% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $134.459.788 | 284.126 | 0,34% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $132.794.974 | 340.596 | 0,34% | Aktien |
| TD Asset Management Inc | $131.847.152 | 338.165 | 0,33% | Aktien |
| Legal & General Group Plc | $127.805.162 | 327.798 | 0,32% | Aktien |
| California Public Employees Retirement System | $124.133.958 | 318.382 | 0,31% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $120.619.879 | 309.369 | 0,31% | Aktien |
| JANE STREET GROUP, LLC | $119.540.274 | 306.600 | 0,30% | Kaufoption |
| VANGUARD ASSET MANAGEMENT, Ltd | $116.069.863 | 297.699 | 0,29% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $114.741.071 | 294.291 | 0,29% | Aktien |
| ANTIPODES PARTNERS Ltd | $113.045.096 | 289.941 | 0,29% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $109.718.328 | 231.845 | 0,28% | Aktien |
| CITADEL ADVISORS LLC | $105.660.190 | 271.000 | 0,27% | Kaufoption |
| RHUMBLINE ADVISERS | $97.580.413 | 250.277 | 0,25% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $97.026.076 | 248.855 | 0,25% | Aktien |
| MACKENZIE FINANCIAL CORP | $93.597.383 | 240.061 | 0,24% | Aktien |
| BloombergSen Inc. | $93.160.317 | 238.940 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92.247.974 | 236.600 | 0,23% | Verkaufsoption |
| Brandywine Global Investment Management, LLC | $89.380.814 | 191.451 | 0,23% | Aktien |
| BANK OF AMERICA CORP /DE/ | $89.069.981 | 228.449 | 0,23% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $85.926.216 | 220.386 | 0,22% | Aktien |
| MILFORD FUNDS LTD | $82.165.029 | 210.739 | 0,21% | Aktien |
| Bridgewater Associates, LP | $79.227.208 | 203.204 | 0,20% | Aktien |
| Prana Capital Management, LP | $75.552.494 | 193.779 | 0,19% | Aktien |
| DANSKE BANK A/S | $73.238.497 | 187.844 | 0,19% | Aktien |
| FRANKLIN RESOURCES INC | $70.965.828 | 182.015 | 0,18% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $70.445.715 | 180.681 | 0,18% | Aktien |
| Quantinno Capital Management LP | $70.407.055 | 180.581 | 0,18% | Aktien |
| ARGENT CAPITAL MANAGEMENT LLC | $69.149.681 | 177.357 | 0,18% | Aktien |
| Retirement Systems of Alabama | $68.081.812 | 174.618 | 0,17% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $66.167.842 | 169.709 | 0,17% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $64.793.090 | 166.183 | 0,16% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $64.665.206 | 165.855 | 0,16% | Aktien |
| HSBC HOLDINGS PLC | $64.431.534 | 165.332 | 0,16% | Aktien |
| AVIVA PLC | $64.264.789 | 164.828 | 0,16% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $64.194.533 | 135.649 | 0,16% | Aktien |
| SEB Asset Management AB | $63.257.255 | 162.244 | 0,16% | Aktien |
| TODD ASSET MANAGEMENT LLC | $62.567.208 | 160.474 | 0,16% | Aktien |
| Swedbank AB | $62.528.998 | 160.376 | 0,16% | Aktien |
| W1M Investment Management Ltd | $61.247.490 | 143.647 | 0,16% | Aktien |
| HARRIS ASSOCIATES L P | $60.080.879 | 154.097 | 0,15% | Aktien |
| Ensign Peak Advisors, Inc | $58.372.381 | 149.715 | 0,15% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $57.747.778 | 148.113 | 0,15% | Aktien |
| CITADEL ADVISORS LLC | $57.235.852 | 146.800 | 0,15% | Verkaufsoption |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57.160.993 | 146.800 | 0,15% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $56.512.217 | 144.944 | 0,14% | Aktien |
| Pictet Asset Management Holding SA | $52.147.803 | 133.739 | 0,13% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $50.752.761 | 130.172 | 0,13% | Aktien |
| Pentwater Capital Management LP | $50.685.700 | 130.000 | 0,13% | Aktien |
| D. E. Shaw & Co., Inc. | $50.554.307 | 129.663 | 0,13% | Aktien |
| APG Asset Management N.V. | $50.368.550 | 147.699 | 0,13% | Aktien |
| AMF Tjanstepension AB | $50.355.853 | 129.154 | 0,13% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $50.349.225 | 129.137 | 0,13% | Aktien |
| EQUITABLE TRUST CO | $49.147.974 | 126.056 | 0,12% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $48.919.124 | 125.469 | 0,12% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $48.197.812 | 123.619 | 0,12% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $47.460.140 | 121.727 | 0,12% | Aktien |
| OpenArc Corporate Advisory, LLC | $47.210.610 | 121.087 | 0,12% | Aktien |
| L1 Capital International Pty Ltd | $46.121.648 | 118.294 | 0,12% | Aktien |
| FIRST TRUST ADVISORS LP | $44.251.579 | 113.498 | 0,11% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $44.046.098 | 112.971 | 0,11% | Aktien |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $43.830.264 | 112.417 | 0,11% | Aktien |
| EP Wealth Advisors, LLC | $43.287.826 | 111.026 | 0,11% | Aktien |
| WOLVERINE TRADING, LLC | $42.597.104 | 101.200 | 0,11% | Kaufoption |
| MERCER GLOBAL ADVISORS INC /ADV | $42.302.070 | 108.497 | 0,11% | Aktien |
Unternehmensinsider 91 Insider · 54 Führungskräfte · 31 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10. Februar 2026 F | 64.842 | 0 | 7 | $-21.483.290 |
| O'Boyle Michael P | President & CEO - Parallon | 26. Februar 2013 A | 21.429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 7. Mai 2026 G | 46.576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16. Februar 2024 F | 22.251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17. November 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17. November 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17. November 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 1. Juli 2005 F | 13.865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12. November 2024 M | 6.843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31. Juli 2024 M | 27.008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16. Februar 2024 F | 17.936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11. November 2022 M | 202.443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11. November 2022 S | 30.807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31. Dezember 2012 A | 335.657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 2. November 2011 M | 144.714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26. Juli 2006 A | 62.173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27. Oktober 2005 A | 26.154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31. Oktober 2004 D | 9.029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 7. Mai 2004 D | 24.177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10. Februar 2026 F | 23.062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 13. Februar 2026 M | 8.853 | 0 | 2 | $-2.747.520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11. Februar 2026 S | 11.993 | 0 | 2 | $-4.126.932 |
| Christopher F. Wyatt | SVP & Controller | 11. Februar 2026 S | 44.379 | 0 | 1 | $-2.020.000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10. Februar 2026 F | 10.407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10. Februar 2026 F | 32.080 | 0 | 1 | $-747.135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13. Februar 2025 F | 11.113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14. November 2024 S | 9.454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12. November 2024 M | 52.702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 5. August 2024 G | 18.526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29. Juli 2024 S | 3.510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25. Juli 2024 S | 17.755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 9. Mai 2024 S | 5.185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18. März 2024 M | 1.576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12. April 2023 M | 24.643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 9. November 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 5. Mai 2021 S | 50.062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18. Februar 2021 F | 5.578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18. Februar 2021 F | 10.122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 1. Mai 2019 A | 194.145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25. Februar 2019 M | 84.157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25. Februar 2019 M | 881.823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25. Februar 2018 M | 7.003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25. Februar 2018 M | 35.546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25. Februar 2018 M | 65.199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23. Mai 2017 M | 26.378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 7. November 2016 M | 110.167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25. Februar 2016 A | 51.965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16. Mai 2012 M | 299.030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 6. Oktober 2009 A | 188.340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27. Februar 2009 M | 13.092 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10. Februar 2026 | 31,60% | Erste Einreichung | — | SEC |
| 22. November 2006 | — | Erste Einreichung | — | SEC | |
| Merrill Lynch Bank USA | 11. September 2006 | — | Erste Einreichung | — | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 4. August 2006 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 207 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 4,67% | 141.320 SH | 8. August 2026 | Täglich |
| BUL · Pacer Funds Trust | 3,91% | 11.437 NS | 30. April 2026 | N-PORT |
| YALL · Tidal Trust I | 3,61% | 9.261 NS | 31. Mai 2026 | N-PORT |
| BWTG · ETF Opportunities Trust | 3,02% | 1.646 NS | 31. Mai 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,32% | 99.335 SH | 8. August 2026 | Täglich |
| ABIG · EA Series Trust | 2,00% | 2.938 NS | 29. Mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,99% | 39.985 NS | 30. April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 31.685 SH | 8. August 2026 | Täglich |
| COWZ · Pacer Funds Trust | 1,64% | 688.264 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,64% | 1.762 NS | 30. April 2026 | N-PORT |
| FEGE · RBB Fund Trust | 1,46% | 74.706 NS | 31. Mai 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,39% | 60.385 SH | 8. August 2026 | Täglich |
| RPG · Invesco Exchange-Traded Fund Trust | 1,30% | 63.448 SH | 8. August 2026 | Täglich |
| TMFE · RBB Fund, Inc. | 1,29% | 2.892 NS | 31. Mai 2026 | N-PORT |
| AMID · EA Series Trust | 1,23% | 3.402 NS | 29. Mai 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,15% | 7.180 NS | 30. April 2026 | N-PORT |
| FMAG · FIDELITY COVINGTON TRUST | 1,12% | 6.544 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,12% | 73.639 NS | 30. April 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,10% | 4.883 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,99% | 89.420 SH | 8. August 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,99% | 48.109.000 SH | 8. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,98% | 3.122 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470.451 SH | 8. August 2026 | Täglich |
| NFRA · FlexShares Trust | 0,88% | 62.176 NS | 30. April 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,87% | 5.693 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,86% | 1.632 NS | 31. Mai 2026 | N-PORT |
| DIVB · iShares Trust | 0,85% | 36.806 SH | 8. August 2026 | Täglich |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,82% | 24.078.000 | 8. August 2026 | Täglich |
| LSEQ · Harbor ETF Trust | 0,81% | 285 NS | 30. April 2026 | N-PORT |
| IXJ · iShares Trust | 0,80% | 81.465 SH | 8. August 2026 | Täglich |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 26.493.000 | 8. August 2026 | Täglich |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,74% | 2.335 SH | 8. August 2026 | Täglich |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,73% | 21.329 NS | 30. April 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 0,68% | 533 NS | 31. Mai 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,68% | 2.698 NS | 30. April 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12.075 SH | 8. August 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | 0,62% | 8.146.000 PA | 8. August 2026 | Täglich |
| FDMO · FIDELITY COVINGTON TRUST | 0,61% | 11.771 NS | 30. April 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,58% | 72.768 NS | 30. April 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,56% | 9.664 NS | 31. Mai 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11.876 SH | 8. August 2026 | Täglich |
| VLLU · Harbor ETF Trust | 0,54% | 54 NS | 30. April 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,53% | 7.404 NS | 30. April 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,51% | 844 NS | 30. April 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,50% | 4.620 NS | 31. Mai 2026 | N-PORT |
| AKAF · ETF Series Solutions | 0,50% | 39 NS | 31. Mai 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22.679.000 | 8. August 2026 | Täglich |
| ROUS · Lattice Strategies Trust | 0,47% | 6.388 NS | 30. April 2026 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,46% | 54.218.000 PA | 8. August 2026 | Täglich |
| CGGR · Capital Group Growth ETF | 0,45% | 290.273 NS | 31. Mai 2026 | N-PORT |